Summary
The consequences of lipid peroxidation on various cell metabolisms are reviewed with special emphasis on low density lipoprotein catabolism and its relation to atherosclerosis. We also present results concerning an original model developed in our laboratories for the study of the effects of singlet oxygen on lipid peroxidation. In this experimental model, lipoproteins are used as a lipidic environment for porphyrins generating singlet oxygen during their photoactivation. We demonstrate that singlet oxygen attack results in the appearance of fatty acid and cholesterol peroxidation products and in alterations of apolipoproteins, but that apolipoprotein alterations markedly differ between low density and high density lipoproteins. Besides its theoretical interest for the study of lipid oxidation in lipid-protein complexes, this model brings new data concerning the consequences of the photoactivation of anticancer porphyrins which are carried by plasma lipoproteins, mainly LDL and HDL.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kappus, H. Lipid peroxidation: Mechanisms, Analysis, Enzymology, and Biological Relevance. In “Oxidative Stress”, H.Sies ed., Academic Press Inc., London; 273 (1985).
Halliwell, B., and Gutteridge, J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem.J., 219: 1 (1984).
Kanofsky, J.R. Singlet oxygen production by lactoperoxidase: halide dependence and quantitation of yield. J.Photochemistry 25: 105 (1984).
Foote, C.S. Photooxidation of Biological Model Compounds. In “Oxygen and Oxy-radicals in Chemistry and Biólogy”, Rodgers, M.A. and Powers, E.L. eds., Academic Press, N.Y.; 425 (1981).
Rosen, G.M., and Freeman, B.A. Detection of superoxide generated by endothelial cells. Proc.Natl.Acad.Sci.USA, 81: 7269 (1984).
Reinecke, J.W., Baker, L., Rosen, H., and Chait, A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J.Clin.Invest., 77: 757 (1986).
Scully, S.P., Segel, G.B., and Lichtman, M.A. Relationship of superoxide production to cytoplasmic free calcium in human monocytes. J.Clin.Invest., 77, 1349–1356 (1986).
Steinbrecher, U.P. Role of superoxide in endothelial-cell modification of low-density lipoproteins. Biochim. Biophys. Acta, 959, 20–30 (1988).
Heinecke, J.W., Rosen, H., Suzuki, L.A., and Chait, A. The role of sulfur-containing amino acids in superoxide production and modification of Low Density Lipoprotein by arterial smooth muscle cells. J.Biol.Chem. 262: 10098 (1987).
Schauenstein, E., Esterbauer, H., and Zollner, H. In “Aldehydes in Biological Systems: Their Natural Occurrence and Biological Activities”, Pion Ldt. London (1977).
Benedetti, A., Comporti, M., and Esterbauer, H. Identification of 4hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim.Biophys.Acta 620, 281–296 (1980).
Takatori, T., and Prevett, O.S. Studies on serum lecithin-cholesterol acyl transferase activity in rat: effect of vitamin E deficiency, oxidized dietary fat or intravenous administration of ozonides or hydroperoxides. Lipids, 9, 1018–1023 (1974).
Wada, K., Miki, H., Etoh, M., Okuda, F., Kumada, T., and Kusukawa, R. The inhibitory effect of lipid peroxide on the activity of the membrane-bound and the solubilized lipoprotein lipase. Japan.Circ.J., 47, 837–842 (1983).
Dianzani, M.U., Bertone, G.F., Bonelli, G., Canuto, R.A., Feo, F., Gabriel, L., Gravela, E., and Pernigotti, L. Interaction of aldehydes and other derivatives of lipid peroxidation with cell structures. Med.Biol.Environ., 4, 345–365 (1976).
Dianzani, M.U. Biological activity of methyl-glyoxal and related activities. In “Submolecular Biology and Cancer” (Ciba Symposium 67), Amsterdam, Excerpta Medica, 245–270 (1979).
Esterbauer, H. In “Free Radicals and Liver Injury”, Poli, G., Cheeseman, K.H., Dianzani, M.U., and Slater, T.F. eds., IRL Press Limited, Oxford, England, 29–47 (1985).
Reiss, U., Tappel, A.L., and Chio, K.S. DNA-malondialdehyde reaction: formation of fluorescent products. Biochem.Biophys.Res.Commun., 921–926 (1972).
Nair, V., Cooper, C.S., Vietti, D.E., and Turner, G.A. The chemistry of lipid peroxidation metabolites: crosslinking reactions of malondialdehyde. Lipids, 21, 6–10 (1986).
Mukai, F.H., and Goldstein, B.D. Mutagenicity of malondialdehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science, 191, 868–869.
Cajelli, E., Ferraris, A., and Brambilla, G. Mutagenicity of 4hydroxynonenal in V79 Chinese hamster cells. Mut.Res., 190, 169–171 (1987).
Vaca, C.E., Wilhelm, J., and Harms-Ringdahl, M. Interaction of lipid peroxidation products with DNA. A review. Mut.Res., 195, 137–149 (1988).
Peng, S.K., and Morin, R.J. Effects on membrane function by cholesterol oxidation derivatives in cultured aortic smooth muscle cells. Artery 14: 85 (1987).
Astruc, M., Rousillon, S., Defay, R., Descomp,B., and Crastes de Paulet, A. DNA and cholesterol biosynthesis in synchronized embryonic rat fibroblasts. Biochim.Biophys.Acta 763: 11 (1983).
Neyses, L., Lochern, R., Stimpel, M., Streuli, R., and Vetter, W. Stereospecific modulation of calcium channel in human erythrocytes by cholesterol and its oxidized derivatives. Biochem.J. 227: 105 (1985).
Cheng, K.P., Nagano, H., Luu, B., Ourisson, G., and Beck, J.P. Chemistry and Biochemistry of Chinese Drugs, Part I. Sterol derivatives cytotoxic to hepatoma cells, isolated from the drug Bombyx cum botryte. J.Chem.Res (S) 217: 2501 (1977).
Maltese, W.A., Reitz, B.A., and Volpe, J.L. Selective decrease in the viability and the sterol content on proliferating versus quiescent glioma cells exposed to 25-hydroxycholesterol. Cancer Res. 41: 3448 (1981).
Peng, S.K., Tham, P., Taylor, C.B., and Mikkelson, B. Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells. Am.J.Nutr. 32: 1033 (1979).
Hietter, H., Trifilieff, E., Richert, L., Beck, J.P., Luu, B., and Ourisson, G. Antagonistic action of cholesterol towards the toxicity of hydroxysterols on cultured hepatoma cells. Biochem.Biophys.Res. Commun. 120: 657 (1984).
Imai, H., Werthessen, N.T., Subramanyam, V.S., LeQuesne, P.W., Soloway, A.H., and Kanisawa, M. Angiotoxicity of oxygenated sterols and possible precursors. Science, 207, 651–652 (1980).
Henriksen, T., Mahoney, E.M., and Steinberg, D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc.Natl.Acad.Sci.U.S.A., 78, 6499–6503 (1981).
Goldstein, J.L., Ho, Y.K., Basu, S.K., and Brown, M.S. Binding sites on macrophages that mediates uptake and degradation of acetylated LDL producing massive cholesterol deposition. Proc.Natl.Acad.Sci.U.S.A., 76, 333–337 (1979).
Gerrity, R.G. The role of the monocyte in atherogenesis. I. Transition of blood borne monocytes into foam cells in fatty lesions. Am.J.Pathol., 103, 181–190 (1981).
Parthasarathy, S., Printz, D.J., Boyd, D., Joy, L., and Steinberg, D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis, 6, 505–510 (1986).
Cathcart, M.K., Morel, D.W., and Chisolm, G. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J.Leuk.Biol., 38, 341–350 (1985).
Hiramatsu, K., Rosen, H., Heinecke, J., Wolfbauer, G., and Chait, A. Superoxide initiates oxidation of low density lipoprotein, by human monocytes. Arteriosclerosis, 7, 55–60 (1987).
Morel, D.W., Hessler, J.R., and Chisolm, G.M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J.Lip.Res., 24, 1070–1076 (1983).
Morel, D.W., DiCorleto, P.E., and Chisolm, G. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis, 4, 357–364 (1984).
Henriksen, T., Evensen, S.A., and Carlander, B. Injury to human endothelial cells in culture induced by low density lipoproteins. Scand.J.Clin.Lab.Invest., 39, 361–368 (1979).
Evensen, S.A., Nilsen, E., and Galdal, K.S. Injury to cultured human fibroblasts induced by low density lipoproteins: potentiating and protective factors. Scand.J.Clin.Lab.Invest., 42, 285–290 (1982).
V.W.M. Van Hinsbergh. LDL cytotoxicity. The state of the art. Atherosclerosis, 53, 113–118 (1984).
Hessler, J.R., Robertson, A.L.Jr., and Chisolm, G.M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis, 32, 213–229 (1979).
Steinbrecher, U.P., Parthasarathy, S., Leake, D.S., Witzum, J.L., and Steinberg, D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc.Natl.Acad.Sci.U.S.A., 81, 3883–3887 (1984).
Parthasarathy, S., Steinbrecher, U.P., Barnett, J., Witzum, J.L., and Steinberg, D. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc.Natl.Acad. Sci.U.S.A., 82, 3000–3004 (1985).
Sparrow, C.P., Parthasarathy, S., and Steinberg, D. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J.Lip.Res., 29, 745–753.
Quinn, M.T., Parthasarathy, S., Fong, L.G., and Steinberg, D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc.Natl.Acad. Sci.U.S.A., 84, 2995–2998.
Quinn, M.T., Parthasarathy, S., and Steinberg, D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc.Natl.Acad.Sci.U.S.A., 85, 2805–2809 (1988).
Curzio, M., Esterbauer, H., Di Mauro, C., Cecchini, G., and Dianzani, M. Chemotactic activity of the lipid peroxidation product 4hydroxynonenal and homologous hydroxyalkenals. Biol.Chem.HoppeSeyler, 367, 321–329 (1986).
Fogelman, A.L., Shechter, I., Seager, J., Hokom, M., Child, J.S., and Edwards, P.A. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc.Natl. Acad. Sci.U.S.A., 77, 2214–2218 (1980).
Haberland, M., Fong, D., and Cheng, L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science, 241, 215–218 (1988).
Yagi, K.,Inagaki, T., Sasaguri, Y., Nakano, R., and Nakashima, T. Formation of lipid-laden cells from cultured aortic smooth muscle cells and macrophages by linoleic acid hydroperoxide and low density lipoprotein. J.Clin.Biochem. Nutr., 3, 87–94 (1987).
Hoff, H.F., Bradley, W.A., Heideman, C.L., Gabatz, J.W., Karagas, M.D., and Gotto, A.M. Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions. Biochim. Biophys.Acta., 573, 361–374 (1979).
Clevidence, B.A., Morton, R.E., West, G., Dusek, D.M., and Hoff, H.F. Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo-B isolated from human aortas. Arteriosclerosis, 4, 196–207 (1984).
Avogaro, P., Bittolo Bon, G., and Cazzolano, G. Presence of modified low density lipoprotein in humans. Arteriosclerosis, 8, 79–87 (1988).
Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H., and Kawai, C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc.Natl. Acad.Sci.U.S.A., 84, 5928–5931 (1987).
Parthasarathy, S., Young, S.G., Witzum, J.L., Pittman, R.C., and Steinberg, D. Probucol inhibits oxidative modification of low density lipoprotein. J.Clin.Invest., 77, 641–644 (1986).
Reyftmann, J.P., Morlière, P., Goldstein, S., Santus, R., Dubertret, L., and Lagrange, D. Interaction of human serum low density lipoproteins with porphyrins: a spectroscopic and photochemical study. Photochem.Photobiol., 40, 721–729 (1984).
Candide, C., Morlière, P., Mazière, J.C., Goldstein, S., Santus, R., Dubertret, L.,- Reyftmann, J.P., and Polonovski, J. In vitro interaction of the photoactive anticancer porphyrin derivative Photofrin II with low density lipoprotein and its delivery to cultured human fibroblasts. FEBS Lett., 207, 133–138 (1986).
Morliére, P., Kohen, E., Reyftmann, J.P., Santus, R., Kohen, C., Mazière, J.C., Goldstein, S., Mangel, W.F., and Dubertret, L. Photosensitization by porphyrin delivered to L cells by human serum low density lipoproteins. A microspectrofluorometr.ic study. Photochem.Photobiol., 46, 183–191 (1987).
Candide, C., Reyftmann, J.P., Santus, R., Mazière, J.C., Morlière, P., and Goldstein, S. Modification of E-amino group of lysines, cholesterol oxidation and oxidized lipid-apoprotein cross-link formation by porphyrin-photosensitized oxidation of human low density lipoproteins. Photochem.Photobiol., 48, 137–146 (1988).
Steinbrecher, U.P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of Apolipoprotein B by lipid peroxide decomposition products. J.Biol.Chem., 262: 3603 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Mazière, J.C. et al. (1990). Lipid Peroxidation and Cellular Functions: in Vitro Models and Relation to in Vivo Observations. In: de Paulet, A.C., Douste-Blazy, L., Paoletti, R. (eds) Free Radicals, Lipoproteins, and Membrane Lipids. NATO ASI Series, vol 189. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-7427-5_31
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7427-5_31
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-7429-9
Online ISBN: 978-1-4684-7427-5
eBook Packages: Springer Book Archive